Ballantyne Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Ballantyne Therapeutics General Information

Description

The company is currently operating under stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 13850 Ballantyne Corporate Place
  • Suite 500
  • Charlotte, NC 28277
  • United States
+1 (704) 000-0000
Primary Industry
Other Commercial Products
Other Industries
Other Consumer Durables
Other Commercial Services
Other Services (B2C Non-Financial)
Corporate Office
  • 13850 Ballantyne Corporate Place
  • Suite 500
  • Charlotte, NC 28277
  • United States
+1 (704) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ballantyne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jan-2023 00000 Completed Stealth
1. Angel (individual) 16-Oct-2015 00000 00000 Completed Stealth
To view Ballantyne Therapeutics’s complete valuation and funding history, request access »

Ballantyne Therapeutics Executive Team (2)

Name Title Board Seat
Michael Roberts Ph.D Chief Executive Officer and Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Ballantyne Therapeutics Board Members (4)

Name Representing Role Since
Brian Doxtator Self Board Member 000 0000
Donald Reynolds Self Board Member 000 0000
Michael Roberts Ph.D Self Chief Executive Officer and Board Member 000 0000
Simon Pedder Ph.D Self Board Member 000 0000
To view Ballantyne Therapeutics’s complete board members history, request access »

Ready to get started?

Request a free trial

Ballantyne Therapeutics FAQs

  • When was Ballantyne Therapeutics founded?

    Ballantyne Therapeutics was founded in 2014.

  • Who is the CEO of Ballantyne Therapeutics?

    Michael Roberts Ph.D is the CEO of Ballantyne Therapeutics.

  • Where is Ballantyne Therapeutics headquartered?

    Ballantyne Therapeutics is headquartered in Charlotte, NC.

  • What industry is Ballantyne Therapeutics in?

    Ballantyne Therapeutics’s primary industry is Other Commercial Products.

  • Is Ballantyne Therapeutics a private or public company?

    Ballantyne Therapeutics is a Private company.

  • What is Ballantyne Therapeutics’s current revenue?

    The current revenue for Ballantyne Therapeutics is 000000.

  • How much funding has Ballantyne Therapeutics raised over time?

    Ballantyne Therapeutics has raised $565K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »